CBIO - Catalyst Biosciences

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

CBIO - Catalyst Biosciences

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

Thu 02'nd Aug 2018

PERIOD 2018-05-03 - 2018-08-02
CHANGE 6.55%
PRICE $10.41






Catalyst Biosciences Stock Analysis

Technical stock analysis for Thu 02'nd Aug 2018

Sell candidate since 2018-07-16 Loss -14.74%
Shorts 0.80% ( 2018-07-13 )
Cash 59.8 mill
Loans n/a
Beta 1.90
ROA -29.43

Catalyst Biosciences gained 6.55% in the last trading day, rising from $9.77 to $10.41 The price has been going up and down for this period, and there has been a -4.58% loss for the last 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 258 011 more shares were traded than the day before. In total, 436 805 shares bought and sold for approximately $4.55 million.


Catalyst Biosciences lies the upper part of a very wide and falling trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $13.59 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -62.36% during the next 3 months and, with 90% probability hold a price between $-0.88 and $5.12 at the end of this period.

Click here for today's Top 5 Trending Companies


A buy signal was issued from a pivot bottom point on Friday July 27, 2018, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Catalyst Biosciences holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $11.79. On a fall, the stock will find some support from the short-term average at $9.91. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

The stock currently holds a RSI14 at 29 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.

Access full RSI 14 and RSI 21 lists

Support & Resistance

Catalyst Biosciences finds support from accumulated volume at $10.38.

Support: $10.38 Price: $10.41 Resistance: $10.46


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.86 between high and low, or 8.96%. For the last week, the stock has had a daily average volatility of 5.86%.

Catalyst Biosciences is oversold on RSI14 (29). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

Hot Trends

ba stock split when to buy oil stock apple inc stocks jcpenney stock price today time to buy tesla stock facebook stock buy at&t inc stock price baba stocks today exxon stock market berkshire hathaway brk b microsoft stock predictions price of prudential common stock zn oil stock quote stock symbol for walt disney company facebook buy or sell stock starbucks stocks analysis

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Proudly made at

in partnership with